World's Best Scientists 2026 revealed!
Kenneth R. Chapman

Kenneth R. Chapman

D-Index & Metrics

Medicine

D-Index
89
Citations
25416
World Ranking
12809
National Ranking
523

Kenneth R. Chapman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kenneth R. Chapman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 459 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kenneth R. Chapman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kenneth R. Chapman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kenneth R. Chapman is affiliated with the University of Toronto in Canada. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine. Throughout their career, they have produced numerous publications, concentrating on various subfields including physiology, anesthesiology and pain medicine, cancer research, and surgery.

The main topics covered in Kenneth R. Chapman's work include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Respiratory Support and Mechanisms
  • Pain Management and Treatment
  • Inhalation and Respiratory Drug Delivery
  • Protease and Inhibitor Mechanisms

They have co-authored extensively with several researchers, among whom the most frequent are:

  • Jean Bourbeau
  • Brandie Walker
  • Wan C. Tan
  • Paul Hernandez
  • François Maltais

Kenneth R. Chapman's publications have appeared in a variety of scientific venues, with a notable frequency in the following journals:

  • Neuromodulation Technology at the Neural Interface
  • American Journal of Respiratory and Critical Care Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • CHEST Journal
  • International Journal of COPD

Some recent papers authored by Kenneth R. Chapman include:

  • "Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial" (2020) published in The Lancet Respiratory Medicine
  • "Once-daily, single-inhaler mometasone-indacaterol-glycopyrronium versus mometasone-indacaterol or twice-daily fluticasone-salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study" (2020) published in The Lancet Respiratory Medicine
  • "Defining a Severe Asthma Super-Responder: Findings from a Delphi Process" (2021) published in The Journal of Allergy and Clinical Immunology In Practice
  • "Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial" (2020) published in Bioimpacts
  • "Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic" (2020) published in CHEST Journal

Best Publications

  • Epidemiology and costs of chronic obstructive pulmonary disease.

    K R Chapman;D M Mannino;J B Soriano;P A Vermeire

  • Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

    Jadwiga A Wedzicha;Donald Banerji;Kenneth R Chapman;Jørgen Vestbo

  • Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

    Shawn D Aaron;Katherine L Vandemheen;Dean Fergusson;François Maltais

  • Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.

    Philip E. Silkoff;Patricia A. McCLEAN;Arthur S. Slutsky;Henry G. Furlott

  • Gender Bias in the Diagnosis of COPD

    Kenneth R. Chapman;Donald P. Tashkin;David J. Pye

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

    Kenneth R Chapman;Jonathan G W Burdon;Eeva Piitulainen;Robert A Sandhaus

  • Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response

    Louis Philippe Boulet;Kenneth R. Chapman;Johanne Côté;Sanjay Kalra

  • Suboptimal asthma control: prevalence, detection and consequences in general practice

    K. R. Chapman;L. P. Boulet;R. M. Rea;E. Franssen

  • Minimal clinically important differences in pharmacological trials.

    Paul W Jones;Kai M Beeh;Kenneth R Chapman;Marc Decramer

  • Medical Personnel's Knowledge of and Ability to Use Inhaling Devices: Metered-Dose Inhalers, Spacing Chambers, and Breath-actuated Dry Powder Inhalers

    Nicola A. Hanania;Richard Wittman;Steven Kesten;Kenneth R. Chapman

  • Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room

    A.S. Rebuck;K.R. Chapman;R. Abboud;P.D. Pare

  • Adverse effects of inhaled corticosteroids

    Nicola A. Hanania;Kenneth R. Chapman;Steven Kesten

  • Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

    Marc L Decramer;Kenneth R Chapman;Ronald Dahl;Peter Frith

  • A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada.

    Michael Jerrett;Murray M. Finkelstein;Jeffrey R. Brook;M. Altaf Arain

  • Asthma Control in Canada Remains Suboptimal: The Reality of Asthma Control (TRAC) Study

    J Mark FitzGerald;Louis-Philippe Boulet;R Andrew McIvor;Sabrina Zimmerman

  • Adult Asthma Consensus Guidelines Update 2003

    Catherine Lemière;Tony Bai;Meyer Balter;Charles Bayliff

  • Relation between income, air pollution and mortality: a cohort study

    Murray M. Finkelstein;Michael Jerrett;Patrick DeLuca;Norm Finkelstein

  • Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

    Chapman Kr;Hurst;Frent Sm;Larbig M

  • Exhaled nitric oxide as a noninvasive assessment of chronic cough.

    Jose M. Chatkin;Khalil Ansarin;Philip E. Silkoff;Patricia McCLEAN

Frequent Co-Authors

Jean Bourbeau
Jean Bourbeau McGill University
Shawn D. Aaron
Shawn D. Aaron Ottawa Hospital
Denis E. O'Donnell
Denis E. O'Donnell Queen's University
François Maltais
François Maltais Université Laval
J. Mark FitzGerald
J. Mark FitzGerald University of British Columbia
Claus Vogelmeier
Claus Vogelmeier Philipp University of Marburg
Nicola A. Hanania
Nicola A. Hanania Baylor College of Medicine
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London
Noel G. McElvaney
Noel G. McElvaney Royal College of Surgeons in Ireland
Malcolm R. Sears
Malcolm R. Sears McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career isn't limited to traditional, in-person degrees. Many students are exploring online options that offer flexibility, affordability, and diverse career pathways in healthcare. For those interested in administrative roles, pursuing medical coding certification cost is a key consideration, as programs vary widely in price and can lead to job opportunities in hospitals and clinics.

Aspiring nurse practitioners can take advantage of cheap online fnp programs, making advanced practice nursing more accessible than ever. Similarly, if you are looking at entry-level nursing, it’s important to understand how much does online nursing school cost, as tuition and fees can vary significantly.

For those pursuing leadership or research roles, phd nursing programs online can open doors to advanced academic and administrative positions. Exploring these online degrees can help you discover affordable, flexible options that align with your goals in the medical field.

Best Scientists Citing Kenneth R. Chapman

Trending Scientists

Recently Published Articles